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The seasonal variations in the occurrence and distribution of pharmaceuticals were evaluated in sea-
water and sediment of Mar Menor lagoon from spring 2010 to winter 2011. A total of 20 pharmaceuticals
in seawater and 14 in sediments were found at concentrations from low ng L1 up to 168 ng L1 (azi-
thromycin) in seawater and from low ng g1 up to 50.3 ng g1 (xylazine) in sediments. Azithromycin,
xylazine and metoprolol were the most ubiquitous compounds in seawater since they were found in all
seawater samples collected. Seven compounds were quantiﬁed in both matrices: clarithromycin, ery-
thromycin, hydrochlorothiazide, irbesartan, losartan, salicylic acid and valsartan. Seasonal distribution
proﬁles revealed different sources of pollutants associated to both, El Albujón watercourse (which re-
ceives the input of a WWTP) and other non-controlled discharges, into the lagoon. In summer the highest
concentrations in seawater for most of the pharmaceuticals were detected close to main touristic nuclei,
probably as consequence of sources such as the excretion from bathers and/or other non-controlled
discharges, these being signiﬁcantly higher than in autumn and winter for antibiotics. On the contrary,
the mean concentration of lorazepam was signiﬁcantly higher in colder seasons than in warmer ones.
Sulfamethoxazole, erythromycin and especially clarithromycin showed hazard quotients higher than 1 in
seawater at some areas of this lagoon indicating a potential risk to aquatic organisms in such speciﬁc
areas.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
The use of pharmaceuticals for both human and veterinary
applications is increasing year by year. However, their environ-
mental behaviour has only been studied in the last two decades.
Pharmaceuticals access the environment by different ways but
their main input is through treated and untreated wastewater
discharges, since conventional wastewater treatments are unable
to completely remove these pollutants (Gros et al., 2010; Ratola
et al., 2012). Consequently their presence in all kinds of con-
tinental water bodies such as rivers (Kolpin et al., 2002; Valcárcel
et al., 2013), lakes (Tixier et al., 2003; Loos et al., 2007; Daneshvar
et al., 2010), marshlands (Vazquez-Roig et al., 2012), reclaimed
water (Panditi et al., 2013), groundwater (Stuart et al., 2012),
protected wetlands (Camacho-Muñoz et al., 2010; Vazquez-Roig
et al., 2011) and even drinking water (Morasch et al., 2010; Val-
cárcel et al., 2011), has been conﬁrmed worldwide. Because of the
discharge of continental water into the sea, some pharmaceuticals.will likely end up in the marine receiving environment and thus
there is a need to increase our knowledge about their occurrence
in such ecosystems. It is only in recent years that some studies
have been conducted to evaluate the input of pharmaceuticals in
coastal areas (Thomas and Hilton 2004; Moreno-González et al.,
2014) in order to understand their fate in the marine environment
(Pait et al., 2006; Alfonso-Olivares et al., 2013; Rodríguez-Navas
et al. 2013). Some studies have focused on their distribution in
seawater (Weigel, 2003; Zhang et al., 2012; Zou et al., 2011; Zheng
et al., 2012; Jiang et al., 2014), but only a few have assessed their
occurrence and distribution in marine sediments (Li et al., 2012;
Stewart, 2013, Shi et al., 2014; Lara-Martín et al., 2014). Although
most pharmaceuticals are mainly hydrophilic and tend to be
present in the dissolved fraction, some of them can undergo spe-
ciﬁc interactions with solid fraction and as a result can be trans-
ferred to sediments. Since sorption processes are a key factor for
the reactivity, mobility, persistence and bioavailability of pollu-
tants in natural waters, there is a need to understand such inter-
actions of pharmaceuticals with sediments and aquatic particles.
The most vulnerable marine environments are coastal areas,
